Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CTP Newsroom

CTP Newsroom

                        Feature Stories Home
          Tobacco Products
          CTP Newsroom
          Listening Session: Developing FDA’s Center for Tobacco Products’ Strategic Plan - 08/22/2023CTP Newsroom Meeting
    Event Title
              Listening Session: Developing FDA’s Center for Tobacco Products’ Strategic Plan


                  August 22, 2023

  Scheduled

             The virtual listening session is free and open to the public.
  
  Share
    Post
    Linkedin

    Email
    PrintDate:
          
  



August 22, 2023   

 
 
        
                                      Time: 
                                      
10:00 AM
ET
                
  Organized By: 
      Organizer
          Center for Tobacco Products
          Food and Drug Administration

 







**On this page**:

Listening Session Recording
	Virtual Listening Session Overview
	Proposed Strategic Goals
	ContactListening Session Recording



Transcript – Listening Session – Aug. 22, 2023

Virtual Listening Session Overview

FDA’s Center for Tobacco Products (CTP) has initiated the development of a 5-year strategic plan to advance its mission. As part of an iterative, center-wide process, CTP has developed five proposed goal areas that have been shaped by staff and leaders from across the center. These goal areas are intended to be interconnected with four proposed cross-cutting themes: health equity, science, transparency, and stakeholder engagement. The center intends to publish its strategic plan by the end of 2023, following receipt and consideration of public input.

On Aug. 22, 2023, CTP held a virtual listening session to give the public an opportunity to verbally provide open public comment on the development of the 5-year strategic plan, including proposed strategic goals. After introductions, the center began the listening session with an overview of the process used to develop CTP’s strategic plan, including proposed goal areas. Registered speakers then had 4 minutes each to verbally share their comments on any topics related to the strategic plan.

To gain additional perspectives as CTP develops its strategic plan, the center seeks public comments on these proposed goal areas or on any other areas that CTP should consider that might not be encapsulated by these proposed goal areas. CTP asks that comments be forward-looking, constructive, and concise in addressing the following questions:

What key features, activities, or initiatives would you like CTP to consider as related to any of these proposed goal areas? For example, in the area of regulations and guidance documents, we would be interested in your feedback on specific regulations and guidance documents FDA should pursue and how they should be prioritized.
	What are measurable short- and long-term outcomes for the proposed goal areas over the next 2 to 5 years?
	What are three specific actions CTP could take in the next 5 years that would have the most impact in significantly reducing tobacco-related death and disease?
	Are there any important features, activities, or initiatives not encapsulated by these proposed goal areas that you believe CTP should consider as part of its strategic plan?The virtual listening session was free and open to the public. Live closed captioning and ASL interpreters were provided during the listening session.

In addition to this listening session, the public had the opportunity to submit electronic or written comments to the docket by Aug. 29, 2023. Visit the *Federal Register* notice for more information.

Proposed Strategic Goals

The proposed goal areas are as follows:

**Develop, Advance, and Communicate Comprehensive and Impactful Tobacco Regulations and Guidance.** This goal includes activities related to the development and implementation of CTP’s regulatory and policy agenda; the articulation and publication of clear and comprehensive public policy statements; and efforts to advance health equity.
	**Ensure Timely, Clear, and Consistent Product Application Review to Protect Public Health.** This goal includes activities related to work processes such as optimizing the efficiency, consistency, and effectiveness of the product application review process; enhancing public understanding of regulatory requirements through transparency and stakeholder engagement efforts; and ensuring that the review process is supported by a strong regulatory science program.
	**Ensure Compliance of Regulated Industry and Tobacco Products Utilizing All Available Tools, Including Robust Enforcement Actions.** This goal includes pursuing enforcement actions to reduce violations; enhancing collaborations with federal and state agencies on tobacco enforcement efforts; and prioritizing agile market intelligence and surveillance to facilitate awareness of and effective responses to the evolving tobacco landscape.
	**Improve Public Health by Enhancing Knowledge and Understanding of CTP Tobacco Product Regulation and the Risks Associated with Tobacco Product Use.** This goal includes timely, clear, and accessible health communications and education to diverse public audiences, including those to discourage youth initiation, encourage cessation, and to inform adults who smoke about the relative risks of tobacco products.
	**Advance Operational Excellence.** This goal includes prioritization of workforce growth, engagement, and retention and CTP’s commitment to diversity, equity, inclusion, and accessibility; modernizing business processes to enhance information management and programmatic efficacy; and seeking and applying needed resources to support CTP’s full portfolio of regulatory activities.



      Contact
      Event Contact
          Contact CTP
				
					Center for Tobacco Products
Food and Drug Administration
Document Control Center
10903 New Hampshire Avenue
Building 71, Room G335
Silver Spring, MD 20993-0002

(9 a.m. - 4 p.m. Eastern)
		
		
					AskCTP@fda.hhs.gov
		
								

    Twitter: https://twitter.com/FDATobacco
    FDA Tobacco Education Resource Library: https://digitalmedia.hhs.gov/tobacco

                                                                                  Content current as of:
      08/23/2023
         
                   
Regulated Product(s)
		 TobaccoMore Meetings,
      Conferences, and
      Workshops
        
        CTP Newsroom

          
                        Feature Stories
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop